Magle Chemoswed Holding AB (publ) (FRA:52X)

Market Cap	2.57M -94.9%
Revenue (ttm)	24.90M -4.1%
Net Income	-16.47M
EPS	-0.80
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0625
Previous Close	n/a
Day's Range	0.0625 - 0.0640
52-Week Range	0.0625 - 2.4400
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 9, 2026

About FRA:52X

Magle Chemoswed Holding AB (publ), together with its subsidiaries, engages in research and development of pharmaceutical and medical device products in Sweden. It provides warfarin sodium products used as anticoagulants for multiple indications; melperone hydrochloride, which is an antipsychotic agent; isradipine, a calcium channel blocker used to treat hypertension; and benserazide hydrochloride, which is used in combination with L-Dopa in the treatment of Parkinson’s disease. The company also offers EmboCept S, a microsphere-based medical dev...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1944
• Employees: 150
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 52X

Financial Performance

Financial numbers in SEK

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 27, 2026

Data Sources Report a data error